Komori
Toyo Gosei (4970) · TargetRestated

Medium-Term Management Plan “TGC300”: Targets of ¥30 billion in net sales, ¥3 billion in ordinary profit and a 10% ordinary profit margin in five years

First written in FY2019-Q2. 10 of 12 entries say "Restated". Latest entry: FY2023-Q2.

12entries
5years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseRestatedFY2019-Q2 – FY2022-Q12018: 12019: 320192020: 420202021: 220212022: 22022
Same theme, other companies
Setting and Achievement of Performance Targets in the Medium-Term Management PlanA theme 843 companies write about · 79 as a headwind · 1121 as a tailwind

The whole theme swung hardest in 2021: 17 of 79 companies on the "Worse" side.

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 134 companies compared. The sentences above are computed from all 134.Comparing 200 of the theme's 1247 threads.
Full recordFilings, disclosures and news, newest first
  1. FY2023-Q2RestatedAnnual report

    「The company will draw on the full strength of the organisation, implement the measures described under “Issues to Be Addressed” in the previous fiscal year's securities report, and work to achieve the medium-term management plan “Beyond500.”」

    The company continues the measures described in the previous fiscal year toward achieving the medium-term management plan “Beyond500.”
  2. FY2022AchievedAnnual report

    「As a result, the medium-term management plan “TGC300,” announced on 10 August 2018 and covering the fiscal years ending March 2019 through March 2023, exceeded its targets one year ahead of schedule. Revenue was ¥33.14 billion, ¥3.14 billion or 10.5% above the plan, ordinary profit was ¥4.79 billion, ¥1.79 billion or 59.8% above the plan, and the ordinary profit margin was 14.5%, compared with the plan targets of revenue of at least ¥30 billion, ordinary profit of at least ¥3 billion and an ordinary profit margin of at least 10%.」

    The company states that it exceeded TGC300's targets of revenue of at least ¥30 billion, ordinary profit of at least ¥3 billion and an ordinary profit margin of at least 10% one year ahead of the plan deadline.
  3. FY2022-Q1RestatedAnnual report

    「We will draw on the full strength of the company, implement the measures described under “Issues to Be Addressed” in the securities report for the previous fiscal year, and work toward achieving the medium-term management plan “TGC300.”」

    The company continues its efforts to achieve TGC300, which targets revenue of at least ¥30 billion, ordinary profit of at least ¥3 billion and an ordinary profit margin of at least 10% in five years.
  4. FY2021RestatedAnnual report

    「The company is working to achieve its five-year targets of revenue of at least ¥30 billion, ordinary profit of at least ¥3 billion and an ordinary profit margin of at least 10%.」

    The company continues the medium-term management plan “TGC300” and its targets of revenue of at least ¥30 billion, ordinary profit of at least ¥3 billion and an ordinary profit margin of at least 10%.
  5. FY2021-Q2RestatedAnnual report

    「Under this medium-term management plan, the company has adopted the concept of “refining the high-purity synthesis capabilities and purification technologies it has accumulated, building a stable supply system that meets customer quality requirements, and achieving the balanced growth of people, organisations and businesses that contributes to technological innovation worldwide.” Its vision is to “address each customer and technology challenge sincerely and from an original perspective, achieve both ultra-high quality and productivity, and become the world's clear No. 1 company.” The company is working to achieve its five-year targets of revenue of at least ¥30 billion, ordinary profit of at least ¥3 billion and an ordinary profit margin of at least 10%.」

    The company continues the concept and vision of the medium-term management plan “TGC300” and its five-year targets of revenue of at least ¥30 billion, ordinary profit of at least ¥3 billion and an ordinary profit margin of at least 10%.
  6. FY2021-Q1RestatedAnnual report

    「Under this medium-term management plan, the company has adopted the concept of “refining the high-purity synthesis capabilities and purification technologies it has accumulated, building a stable supply system that meets customer quality requirements, and achieving the balanced growth of people, organisations and businesses that contributes to technological innovation worldwide.” Its vision is to “address each customer and technology challenge sincerely and from an original perspective, achieve both ultra-high quality and productivity, and become the world's clear No. 1 company.” The company is working to achieve its five-year targets of revenue of at least ¥30 billion, ordinary profit of at least ¥3 billion and an ordinary profit margin of at least 10%.」

    The company continues the concept and vision of the medium-term management plan “TGC300” and its five-year targets of revenue of at least ¥30 billion, ordinary profit of at least ¥3 billion and an ordinary profit margin of at least 10%.
  7. FY2020RestatedAnnual report

    「Under this medium-term management plan, the company has adopted the concept of “refining the high-purity synthesis capabilities and purification technologies it has accumulated, building a stable supply system that meets customer quality requirements, and achieving the balanced growth of people, organisations and businesses that contributes to technological innovation worldwide.” Its vision is to “address each customer and technology challenge sincerely and from an original perspective, achieve both ultra-high quality and productivity, and become the world's clear No. 1 company.” The company is working to achieve its five-year targets of revenue of at least ¥30 billion, ordinary profit of at least ¥3 billion and an ordinary profit margin of at least 10%.」

    The company continues the concept and vision of TGC300 and its five-year targets of revenue of at least ¥30 billion, ordinary profit of at least ¥3 billion and an ordinary profit margin of at least 10%.
  8. FY2020-Q3RestatedAnnual report

    「Under this medium-term management plan, the company has adopted the concept of “refining the high-purity synthesis capabilities and purification technologies it has accumulated, building a stable supply system that meets customer quality requirements, and achieving the balanced growth of people, organisations and businesses that contributes to technological innovation worldwide.” Its vision is to “address each customer and technology challenge sincerely and from an original perspective, achieve both ultra-high quality and productivity, and become the world's clear No. 1 company.” The company is working to achieve its five-year targets of revenue of at least ¥30 billion, ordinary profit of at least ¥3 billion and an ordinary profit margin of at least 10%.」

    The company continues the concept and vision of the medium-term management plan “TGC300” and its five-year targets of revenue of at least ¥30 billion, ordinary profit of at least ¥3 billion and an ordinary profit margin of at least 10%.
  9. FY2020-Q2RestatedAnnual report

    「Under this medium-term management plan, the company has adopted the concept of “refining the high-purity synthesis capabilities and purification technologies it has accumulated, building a stable supply system that meets customer quality requirements, and achieving the balanced growth of people, organisations and businesses that contributes to technological innovation worldwide.” Its vision is to “address each customer and technology challenge sincerely and from an original perspective, achieve both ultra-high quality and productivity, and become the world's clear No. 1 company.” The company is working to achieve its five-year targets of revenue of at least ¥30 billion, ordinary profit of at least ¥3 billion and an ordinary profit margin of at least 10%.」

    The company continues the concept and vision of the medium-term management plan “TGC300” and its five-year targets of revenue of at least ¥30 billion, ordinary profit of at least ¥3 billion and an ordinary profit margin of at least 10%.
  10. FY2020-Q1RestatedAnnual report

    「Under this medium-term management plan, the company has adopted the concept of “refining the high-purity synthesis capabilities and purification technologies it has accumulated, building a stable supply system that meets customer quality requirements, and achieving the balanced growth of people, organisations and businesses that contributes to technological innovation worldwide.” Its vision is to “address each customer and technology challenge sincerely and from an original perspective, achieve both ultra-high quality and productivity, and become the world's clear No. 1 company.” The company is working to achieve its five-year targets of revenue of at least ¥30 billion, ordinary profit of at least ¥3 billion and an ordinary profit margin of at least 10%.」

    The company continues the concept and vision of the medium-term management plan “TGC300” and its five-year targets of revenue of at least ¥30 billion, ordinary profit of at least ¥3 billion and an ordinary profit margin of at least 10%.
  11. FY2019-Q3RestatedAnnual report

    「To enhance corporate value and the common interests of shareholders, the company formulated the five-year medium-term management plan “TGC300” and launched it in the current fiscal year. Under this medium-term management plan, the company has adopted the concept of “refining the high-purity synthesis capabilities and purification technologies it has accumulated, building a stable supply system that meets customer quality requirements, and achieving the balanced growth of people, organisations and businesses that contributes to technological innovation worldwide.” Its vision is to “address each customer and technology challenge sincerely and from an original perspective, achieve both ultra-high quality and productivity, and become the world's clear No. 1 company.” The company is working to achieve its five-year targets of revenue of at least ¥30 billion, ordinary profit of at least ¥3 billion and an ordinary profit margin of at least 10%.」

    The company continues its five-year medium-term management plan “TGC300” and its targets of revenue of at least ¥30 billion, ordinary profit of at least ¥3 billion and an ordinary profit margin of at least 10% in five years.
  12. FY2019-Q2First statedAnnual report

    「Under this medium-term management plan, the company has adopted the concept of “refining the high-purity synthesis capabilities and purification technologies it has accumulated, building a stable supply system that meets customer quality requirements, and achieving the balanced growth of people, organisations and businesses that contributes to technological innovation worldwide.” Its vision is to “address each customer and technology challenge sincerely and from an original perspective, achieve both ultra-high quality and productivity, and become the world's clear No. 1 company.” The company is working to achieve its five-year targets of revenue of at least ¥30 billion, ordinary profit of at least ¥3 billion and an ordinary profit margin of at least 10%.」

    The five-year plan announced on 10 August 2018 and launched in the current fiscal year. It targets revenue of at least ¥30 billion, ordinary profit of at least ¥3 billion and an ordinary profit margin of at least 10% in five years, based on high-purity synthesis capabilities, purification technologies, stable supply, and the growth of people, organisations and businesses.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
Toyo Gosei's next results are scheduled for 2026-11-06. Read the earnings preview
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.